Fig. 8

Mechanism exploration of TGFBI functions 2. A The molecular docking for TGFBIp and integrin αvβ3. B The flow cytometry analysis of the expression levels of integrin αvβ3 on the membranes of two ovarian cancer cells. C, D WB analysis of TGFBI EO cell lines after treatment with specific integrin αvβ3 inhibitor Cyclo (-RGDyK). KO knock out, EO over-expression. *p < 0.05, **p < 0.01, ***p < 0.001